BioSpace News Archive

Volpara today announced the first 25 sales and installations of its Volpara Enterprise software, which helps breast imaging providers deliver high quality, personalized breast screening. Installations of VolparaEnterprise software have recently been completed at stand-alone breast imaging clinics, radiology practices, community hospitals and academic medical centers across the United States, Canada, Australia and New Zealand.

Epic Sciences adds simultaneous MSI and CIN measurements, also known as genomic scarring analysis, to the single cell NGS workflow for clinical research of immuno-oncology therapies.

On a year to date basis, revenue rose 6.2% to $96.1M, as compared to $90.5M through nine of months of 2016.

Mapi Research Trust, the leading curator and license distributor of COAs, has partnered with Sanofi to develop the Sanofi PRO questionnaires website showcasing all PRO questionnaires developed or currently in development by Sanofi across various therapeutic areas and diseases.

Aldeyra will hold a conference call on Thursday, November 9, 2017, at 8:00 a.m. EST to discuss the results.

The device was one of the eight innovations selected among nearly fifty submissions.

As part of the Sublicense Agreement, Baxalta agreed to pay Xenetic a one-time payment of $7.5 million and single digit royalty payments based upon net sales of the products covered under the sublicense throughout the term of the agreement.

The oral presentation reviews the central role of toxic beta amyloid (Aβ) oligomers in the development and progression of AD.

The payment for the surgical procedure includes the cost of the Argus II.

Dr. Bates will serve on the Axial senior management team and will be responsible for all aspects of regulatory support and operations.